Loss of MTSS1 Expression is an Independent Prognostic Factor for Hilar Cholangiocarcinoma

被引:20
|
作者
Wang, Fei [1 ]
Liu, Yulong [2 ]
Zhang, Hao [3 ]
机构
[1] Eastern Hepatobiliary Hosp, Dept Surg, Shanghai, Peoples R China
[2] Soochow Univ, Affiliated Hosp 2, Emergency Ctr, Suzhow, Peoples R China
[3] Fudan Univ, Hua Shan Hosp, Dept Gen Surg, Shanghai 200040, Peoples R China
关键词
Cholangiocarcinoma; MTSS1; Immunohistochemistry; Prognosis; PERIPHERAL INTRAHEPATIC CHOLANGIOCARCINOMA; SURGICAL-TREATMENT; BREAST-CANCER; MIM-B; METASTASIS; PROGRESSION; CARCINOMA; SURVIVAL; GENE; MANAGEMENT;
D O I
10.1007/s12253-013-9649-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis suppressor 1 (MTSS1) is a novel metastasis suppressor gene in a variety of cancers. This study aimed to detect MTSS1 expression in normal and cancerous tissue specimens from Chinese patients with hilarcholangiocarcinoma to determine the association with clinicopathological parameters and survival. Tissue microarrays containing normal and tumor specimens were constructed using paraffin blocks from 61 patients for immunohistochemical analysis of MTSS1 expression. A subgroup of these tissues was verified by Western blot analysis. MTSS1 protein was expressed in 24 of 61 cases (39.3 %) of tumor tissues, compared to that in 22 of 26 (84.6 %) of non-neoplastic bile duct epithelium and in 26 of 26 (100 %) of adjacent normal liver cells. Loss of MTSS1 expression was associated with lymph node metastases of cholangiocelluarcarcinoma and tumorcellde-differentiation.MTSS1 expression inversely associated with tumor recurrence and overall survival of the patients by univariate and multivariate analyses. MTSS1 expression was significantly decreased in human hilarcholangiocarcinoma and lost MTSS1 expression was associated with pooroverall survival and tumor recurrences in cholangiocarcinoma patients. Thus, MTSS1 expression represents an independent predictor for tumor recurrence and overall survival in patients with cholangiocarcinoma.
引用
收藏
页码:815 / 820
页数:6
相关论文
共 50 条
  • [31] Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma
    Taylor, Matthew D.
    Bollt, Oana
    Iyer, Soumya C.
    Robertson, Gavin P.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (1-2) : 15 - 23
  • [32] Analysis of RPL37A, MTSS1, and HTRA1 expression as potential markers for pathologic complete response and survival
    Carrara, Guilherme Freire Angotti
    Evangelista, Adriane Feijo
    Scapulatempo-Neto, Cristovam
    Abrahao-Machado, Lucas Faria
    Morini, Mariana Andozia
    Kerr, Ligia Maria
    Folgueira, Maria Aparecida Azevedo Koike
    da Costa Vieira, Rene Aloisio
    BREAST CANCER, 2021, 28 (02) : 307 - 320
  • [33] Cluster of Differentiation 24 Expression Is an Independent Prognostic Factor of Adverse Outcome in Cervical Carcinoma
    Huang, Lee-Wen
    Lee, Chin-Cheng
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (02) : 325 - 330
  • [34] Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma
    Huang, Xiu-Yan
    Huang, Zi-Li
    Xu, Bin
    Chen, Zi
    Re, Thomas Joseph
    Zheng, Qi
    Tang, Zhao-You
    Huang, Xin-Yu
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [35] Prognostic value of pAMPKa/ADM2/VEGF expression in hilar cholangiocarcinoma
    Wang, Jingying
    Wang, Jinmeng
    Zhu, Li
    Li, Wenfeng
    Yu, Guanzhen
    Xu, Yunsheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 1783 - 1791
  • [36] Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma
    Su, Min-Cheng
    Chen, Chun-Ting
    Huang, Fang-I
    Chen, Yu-Ling
    Jeng, Yung-Ming
    Lin, Chiao-Ying
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (12) : 934 - 939
  • [37] Positive ADAR1 expression indicated poor prognosis in hilar cholangiocarcinoma
    Hao, Xuwen
    Li, Shuhong
    Xu, Xinsheng
    Li, Dan
    Kang, Lili
    Liu, Yin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (04): : 2458 - 2465
  • [38] Ezrin Expression Is an Independent Prognostic Factor in Gastro-intestinal Cancers
    Arumugam, Prabhu
    Partelli, Stefano
    Coleman, Stacey J.
    Cataldo, Ivana
    Beghelli, Stefania
    Bassi, Claudio
    Wijesuriya, Nilukushi
    Aleong, Jo-Anne Chin
    Froeling, Fieke E. M.
    Scarpa, Aldo
    Kocher, Hemant M.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (12) : 2082 - 2091
  • [39] NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer
    Villodre, Emilly S.
    Gong, Yun
    Hu, Xiaoding
    Huo, Lei
    Yoon, Esther C.
    Ueno, Naoto T.
    Woodward, Wendy A.
    Tripathy, Debu
    Song, Juhee
    Debeb, Bisrat G.
    CANCERS, 2020, 12 (12) : 1 - 14
  • [40] Notch1 Is an Independent Prognostic Factor for Patients With Glioma
    Li, Jiang
    Cui, Ying
    Gao, Guodong
    Zhao, Zhenwei
    Zhang, Hua
    Wang, Xuelian
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (08) : 813 - 817